Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for PatientsGlobeNewsWire • 08/20/19
Biogen Inc. (BIIB) CEO Michel Vounatsos on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/23/19
Biogen Earnings: Here's What Investors Are Hoping To See In ReportInvestors Business Daily • 07/22/19